Value sales of cough, cold and allergy (hay fever) remedies increased in Greece in 2025, although growth slowed compared to 2024. Volume growth was notably modest across most categories, reflecting the absence of a significant surge in illness during the year. The increase in value was primarily dri ...

Cough, cold and allergy (hay fever) remedies is expected to register moderate current value growth in Portugal in 2025. New viruses that are resistant to antibiotics support value sales. In addition, an ageing population which takes longer to recover from colds and coughs, also supports value sales. ...

Cough, cold and allergy (hay fever) remedies is recording solid value growth in Malaysia in 2025, as local consumers continue to take proactive steps in managing respiratory health. Ongoing risks from COVID-19 and influenza cases maintain demand, while generic options are also seeing rising uptake, ...

Consumer health in Denmark has seen positive growth in current value terms in 2025. The Danish economy has remained relatively strong in 2025 with stable inflation rates, lower interest rates, increasing real wages and an increase in consumer spending. However, many consumers continue to spend more ...

The consumer health market in Uruguay is poised for continued growth in current value terms in 2025, albeit at a slower pace than in 2024, when the country rebounded from the Argentine crisis. The appreciation of Argentina’s official exchange rate is reducing cross-border shopping, which together wi ...

The market for cough, cold, and allergy remedies in Uruguay will continue to expand in current value terms in 2025, supported by a more favourable economic environment and climate-related factors. Warmer weather during the first half of the year, combined with increased outdoor activity, has contrib ...

Sales of cough, cold and allergy (hay fever) remedies have seen continued growth in 2025 in current value terms. This has been partly driven by strong growth in antihistamines/allergy remedies. As Danish consumers spend more time outside, and the allergy season becomes longer due to the impact of cl ...

Value sales of paediatric consumer health products increased in Taiwan in 2025. The most dynamic category was paediatric vitamins and dietary supplements. Despite the ongoing low birth rate, Taiwanese parents remain highly willing to invest in children’s health supplements, provided the products are ...

In 2025, cough, cold and allergy (hay fever) remedies in Slovakia is returning to steady growth in retail value, following the turbulence of earlier shortages. Although lingering supply gaps and inflationary pressures still shape consumer behaviour, purchasing patterns are becoming more stable. The ...

Cough, cold and allergy (hay fever) remedies is posting slight growth in retail value sales in Sweden in 2025, with allergy remedies the main driver. Longer and warmer summers are extending pollen seasons in the country, contributing to a rise in allergy cases and higher demand for treatment. Euromo ...

Value sales of cough, cold, and allergy (hay fever) remedies increased in Taiwan in 2025. Following the full reopening of society, Taiwan continued to experience several waves of influenza through to 2025. Public concern was heightened in February 2025 by the sudden passing of prominent Taiwanese ce ...

Value sales of cough, cold and allergy (hay fever) remedies are positive in Slovenia in 2025, thanks to stable consumer demand. Several factors positively impact the performance of the category, including the continued post-pandemic “return to normal” with rising cases of colds and influenza, alongs ...

Cough, cold and allergy (hay fever) remedies witnessed ongoing growth in 2025 thanks to the slight increase in VAT at the beginning of 2025. In addition, poor air quality, made worse by political violence and the destruction of buildings, increased allergies due to the amount of dust and debris in t ...

Cough, cold and allergy (hay fever) remedies in Romania will see continued growth in current value terms in 2025. This performance is being driven by a higher incidence of viral infections and respiratory issues stemming from urban pollution, prompting Romanians to seek faster treatments for their s ...

Sales of cough, cold and allergy (hay fever) remedies have seen steady growth in current value terms in 2025. The category's momentum is being driven by the growing consumption of combination products – cough, cold and allergy (hay fever) remedies. This reflects the growing consumer demand for value ...

Cough, cold and allergy (hay fever) remedies is expected to register healthy current value growth in Latvia in 2025. There was a high level of cough and colds early in the year, and then spring arrived early, which boosted sales of allergy remedies. In particular healthy value growth is expected in ...

The sustained growth of cough, cold and allergy (hay fever) remedies in the Netherlands can be attributed to the strong demand for decongestants in 2025. A flu epidemic was officially declared in January 2025, with sales also fuelled by the active promotion of more advanced and effective products. T ...

Current value sales of cough, cold and allergy (hay fever) remedies rose substantially in Turkey in 2025 albeit at a slower rate than in the previous year of the review period as inflation remained high. Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies in Turkey report offers ...

Retail value sales of cough, cold and allergy (hay fever) remedies are set to rise in current terms in Vietnam in 2025. Growth is being driven by environmental changes and shifting consumer habits. An early flu season brought a noticeable rise in cases at major hospitals, with humid post-Lunar New Y ...

Poland has seen an increased incidence of allergy sufferers in 2025. According to data from Jutro Medical, the number of allergy diagnoses at the beginning of 2025 rose by 21% compared to the same period in the previous year. Notably, experts are linking allergies to cognitive effects such as fatigu ...

Cough, cold and allergy (hay fever) remedies recorded moderate value growth in Hungary in 2025. The category remains popular among consumers for its ability to alleviate symptoms of common colds and coughs. When initial symptoms appear, many consumers opt to self-medicate with over-the-counter produ ...

Consumer demand for cough, cold and allergy (hay fever) remedies is highly seasonal in Egypt, with cough and cold sales peaking from late autumn through to early spring. This increase is driven by a higher incidence of respiratory illnesses during these periods, as colder weather and indoor crowding ...

Value sales of cough, cold, and allergy (hay fever) remedies recorded a slight decline in 2025. However, this primarily reflected a return to normal consumption levels following the exceptional sales peaks experienced in 2023 and 2024. Euromonitor International's Cough, Cold and Allergy (Hay Fever) ...

In 2025, cough, cold and allergy (hay fever) remedies in Costa Rica is expected to register moderate current value growth. Value growth is dampened somewhat by growing demand for generics and consumers also responding to price promotions. Combination products are expected to register the highest val ...

Retail sales of cough, cold, and allergy (hay fever) remedies in Kazakhstan are expected to rise in current value terms in 2025, although this is mainly due to higher prices driven by persistent inflation. Despite this, there remains strong consumer demand for effective and fast-acting treatments, p ...